SCHEMBL7196068

SCHEMBL7196068

CCOC(=S)N(c1ccc(C(=O)O)cc1)c1ccccc1C=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.38
MEN1 O00255 7/20 0.38
MAPK1 P28482 1/20 0.38
ALDH1A1 P00352 4/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
CTDSP1 Q9GZU7 1/20 0.36
APAF1 O14727 1/20 0.36
TDP2 O95551 1/20 0.36
NSD2 O96028 1/20 0.36
CASP3 P42574 1/20 0.36
CACNA1B Q00975 1/20 0.36
APBA1 Q02410 1/20 0.36
HKDC1 Q2TB90 1/20 0.36
SENP8 Q96LD8 1/20 0.36
SENP7 Q9BQF6 1/20 0.36
SENP6 Q9GZR1 1/20 0.36
APOBEC3G Q9HC16 1/20 0.36
SAE1 Q9UBE0 1/20 0.36
UBA2 Q9UBT2 1/20 0.36
POLB P06746 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7188393 0.90 ALDH1A1 (0.38) KMT2AMEN1ALDH1A1SMN1; SMN2CTDSP1
SCHEMBL7542195 0.88 CTDSP1 (0.43) KMT2AMEN1MAPK1ALDH1A1SMN1; SMN2
SCHEMBL7190543 0.86 ALDH1A1 (0.40) KMT2AMEN1ALDH1A1SMN1; SMN2CTDSP1
SCHEMBL7190201 0.85 ALDH1A1 (0.39) KMT2AMEN1MAPK1ALDH1A1SMN1; SMN2
SCHEMBL7183302 0.84 MEN1 (0.40) KMT2AMEN1MAPK1ALDH1A1SMN1; SMN2
SCHEMBL7189902 0.78 CTDSP1 (0.45) KMT2AMEN1ALDH1A1SMN1; SMN2CTDSP1
SCHEMBL7195969 0.77 ALDH1A3 (0.38) KMT2AMEN1ALDH1A1SMN1; SMN2CTDSP1
SCHEMBL7195265 0.77 HRH3 (0.37) KMT2AMEN1MAPK1ALDH1A1LMNA
SCHEMBL7191776 0.76 ALDH1A1 (0.39) KMT2AMEN1MAPK1ALDH1A1SMN1; SMN2
SCHEMBL7195416 0.76 TSHR (0.44) KMT2AMEN1ALDH1A1SMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1304924-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS Bayer Aktiengesellschaft (DE) 2003-05-02 EP disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed
WO-2002005646-A2 COMPOSITIONS FOR REPELLING CRAWLING INSECTS S.C. JOHNSON & SON, INC. (US) (US) 2002-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 KMT2A 3439/4885MEN1 3828/4885MAPK1 4211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.